<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Electronic Health Records | Yau Research Group</title>
    <link>https://cwcyau.github.io/category/electronic-health-records/</link>
      <atom:link href="https://cwcyau.github.io/category/electronic-health-records/index.xml" rel="self" type="application/rss+xml" />
    <description>Electronic Health Records</description>
    <generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Thu, 07 Aug 2025 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://cwcyau.github.io/media/icon_hu_7613a4a452ac7087.png</url>
      <title>Electronic Health Records</title>
      <link>https://cwcyau.github.io/category/electronic-health-records/</link>
    </image>
    
    <item>
      <title>SurvivEHR preprint now available</title>
      <link>https://cwcyau.github.io/post/2025-08-07_survivehr_medrxiv/</link>
      <pubDate>Thu, 07 Aug 2025 00:00:00 +0000</pubDate>
      <guid>https://cwcyau.github.io/post/2025-08-07_survivehr_medrxiv/</guid>
      <description>&lt;p&gt;A preprint of work by &lt;a href=&#34;../../authors/gadd&#34;&gt;Charles Gadd&lt;/a&gt; describing &lt;a href=&#34;https://www.medrxiv.org/content/10.1101/2025.08.04.25332916v1&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&amp;ldquo;SurvivEHR: a competing risks, time-to-event foundation model for multiple long-term conditions from primary care electronic health records&amp;rdquo;&lt;/a&gt; is now available on medRxiv.&lt;/p&gt;
&lt;p&gt;&amp;ldquo;Multiple long-term conditions (MLTCs) or multimorbidity &amp;ndash; the co-occurrence of multiple chronic conditions &amp;ndash;presents a growing challenge for primary care. Current predictive models often target single outcomes and overlook the complexities of time-to-event risk in real-world, longitudinal health data. Here, we present SurvivEHR, a generative transformer-based foundation model trained on over 7.6 billion coded events from 23 million patients in UK primary care. SurvivEHR introduces a competing risk time-to-event pretraining objective that enables accurate forecasting of future diagnoses, investigations, medications, and mortality. We demonstrate that SurvivEHR achieves strong risk stratification performance, captures clinically meaningful trajectories, and outperforms benchmark survival models across multiple tasks. The model also transfers effectively to fine-tuned prognostic tasks, particularly in low-resource settings. By learning patient trajectories directly from routine health records, SurvivEHR offers a scalable and privacy-preserving approach for building generalisable clinical risk tools that address the complexity of MLTCs in primary care..&amp;rdquo;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>New report on Synthetic Data for Development of AI</title>
      <link>https://cwcyau.github.io/post/2025-07-01_phg_synthetic/</link>
      <pubDate>Tue, 01 Jul 2025 00:00:00 +0000</pubDate>
      <guid>https://cwcyau.github.io/post/2025-07-01_phg_synthetic/</guid>
      <description>&lt;p&gt;Christopher Yau has contributed as a member of the expert working group to a new report &lt;a href=&#34;2025-08-07_SurvivEHR_medrxiv.md&#34;&gt;&amp;ldquo;The Synthetic Data for Development of AI as a Medical Device&amp;rdquo;&lt;/a&gt; now available via PHG Foundation:&lt;/p&gt;
&lt;p&gt;&amp;ldquo;Synthetic data is artificially generated data that reflects the properties and relationships found in real data. While synthetic data can play an important role in AIaMD development, its use in regulatory submissions introduces specific considerations, especially when it constitutes a substantial part of the evidence package.&lt;/p&gt;
&lt;p&gt;The Synthetic Data for Development of AI as a Medical Device (AIaMDs) report, produced by the Medicines and Healthcare products Regulatory Agency (MHRA) and the PHG Foundation, outlines these considerations, building on and complementing existing regulatory guidance. This marks an important and exciting first step for manufacturers and notified bodies collectively navigating this evolving landscape. The report provides crucial groundwork, though more work is required to move past these preliminary ideas.&amp;rdquo;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Multiple Long-Term Conditions Research Update</title>
      <link>https://cwcyau.github.io/post/2023-10-12_mltc/</link>
      <pubDate>Thu, 12 Oct 2023 00:00:00 +0000</pubDate>
      <guid>https://cwcyau.github.io/post/2023-10-12_mltc/</guid>
      <description>&lt;p&gt;We continue to contribute to the &lt;a href=&#34;https://mumpredict.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;MUM-PREDICT&lt;/a&gt; and &lt;a href=&#34;https://www.birmingham.ac.uk/research/applied-health/research/optimal/index.aspx&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;OPTIMAL&lt;/a&gt; projects over the last six months including:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://openresearch.nihr.ac.uk/documents/3-21&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Artificial Intelligence for Multiple Long-term conditions (AIM): A consensus statement from the NIHR AIM consortia&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://bmjopen.bmj.com/content/13/2/e068718.abstract&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UK&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://link.springer.com/article/10.1186/s12916-022-02722-5&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-03013-3&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;The development of a core outcome set for studies of pregnant women with multimorbidity&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://bmjopen.bmj.com/content/13/10/e073162.abstract&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Detection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy: a signal detection study protocol&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ul&gt;
</description>
    </item>
    
    <item>
      <title>New paper with Breaking Free Online on substance abuse</title>
      <link>https://cwcyau.github.io/post/2023-10-01_jamiaopen/</link>
      <pubDate>Sun, 01 Oct 2023 00:00:00 +0000</pubDate>
      <guid>https://cwcyau.github.io/post/2023-10-01_jamiaopen/</guid>
      <description>&lt;p&gt;Congratulations to &lt;a href=&#34;../../author/franziska-gunther&#34;&gt;Franziska Gunther&lt;/a&gt; on her collaborative work with &lt;a href=&#34;https://www.breakingfreeonline.com/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Breaking Free Online&lt;/a&gt; on &lt;a href=&#34;https://academic.oup.com/jamiaopen/article/6/3/ooad072/7259137&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Identifying factors associated with user retention and outcomes of a digital intervention for substance use disorder: a retrospective analysis of real-world data&lt;/a&gt; which has been published in JAMIA Open.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>MIE 2023 success </title>
      <link>https://cwcyau.github.io/post/2023-05-22_mie2023/</link>
      <pubDate>Mon, 22 May 2023 00:00:00 +0000</pubDate>
      <guid>https://cwcyau.github.io/post/2023-05-22_mie2023/</guid>
      <description>&lt;p&gt;Congratulations to &lt;a href=&#34;../../author/franziska-gunther&#34;&gt;Franziska Gunther&lt;/a&gt; on her collaborative work with Breaking Free Online which was presented at &lt;a href=&#34;https://www.mie2023.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;MIE 2023&lt;/a&gt;: &lt;a href=&#34;https://eprints.whiterose.ac.uk/198537/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;On the difficulty of predicting engagement with digital interventions for substance use disorders&lt;/a&gt;.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>MUM-PREDICT: HDRUK Team of the Year</title>
      <link>https://cwcyau.github.io/post/2022-12-31_mumpredict/</link>
      <pubDate>Sat, 31 Dec 2022 00:00:00 +0000</pubDate>
      <guid>https://cwcyau.github.io/post/2022-12-31_mumpredict/</guid>
      <description>&lt;p&gt;We are proud to have been part of a glittering array of publications arising from our contribution to the &lt;a href=&#34;https://mumpredict.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;MUM-PREDICT&lt;/a&gt; projects over the last 12 months. The team also won the &lt;a href=&#34;https://www.hdruk.ac.uk/news/winners-announced-for-hdr-uks-annual-awards/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Health Data Research UK Team of the Year 2022 award&lt;/a&gt;:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://link.springer.com/article/10.1186/s41512-022-00137-7&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Protocol for development and validation of postpartum cardiovascular disease (CVD) risk prediction model incorporating reproductive and pregnancy-related candidate predictors&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;[Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019](&lt;a href=&#34;https://link.springer.com/article/10.1186/s12916-022-02722-5]&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;https://link.springer.com/article/10.1186/s12916-022-02722-5]&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://proceedings.mlr.press/v193/gadd22a.html&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;mmVAE: multimorbidity clustering using Relaxed Bernoulli Î²-Variational Autoencoders&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://bmjopen.bmj.com/content/13/2/e068718.abstract&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UK &lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ul&gt;
</description>
    </item>
    
  </channel>
</rss>
